Domenica M. Rubino, MD
https://reachmd.com/profiles/domenica-m-rubino-md/jmQBM0/
Domenica M. Rubino, MD is board certified in Obesity Medicine, Endocrinology, Diabetes & Metabolism, and Internal Medicine. She has extensive experience in the care of the overweight patient as well as clinical research for the development of pharmaco-therapeutic agents in the management of obesit…
John E. Anderson, MD
https://reachmd.com/profiles/john-e-anderson-md/LbgJdA/
Dr. John E. Anderson practices internal medicine and diabetes at the Frist Clinic in Nashville, Tennessee. He has served as a Past President of the 38 member multi-specialty clinic, and has served leadership roles at Centennial Medical Center, a 670 bed HCA tertiary care referral hospital. He has s…
Carol Wysham, MD
https://reachmd.com/profiles/carol-wysham-md/LqkMQj/
Carol Wysham, MD, is clinical associate professor of medicine at the University of Washington School of Medicine and is Section Head of the Department of Diabetes and Endocrinology at Rockwood Clinic in Spokane, Washington. Dr. Wysham obtained her medical degree from the University of Iowa College …
Jane J. Kim, M.D.
https://reachmd.com/profiles/jane-j-kim-md/OBa3d8/
Dr. Jane Kim is a board-certified pediatric endocrinologist at Rady Children's Hospital-San Diego and an assistant professor in the Division of Pediatric Endocrinology at UC San Diego School of Medicine. Her medical education began at the University of Toronto, followed by a pediatric residency at…
Semaglutide Kidney Outcomes Trial Ends Early; Findings Appear Positive
https://reachmd.com/news/semaglutide-kidney-outcomes-trial-ends-early-findings-appear-positive/2452822/
Novo Nordisk has decided to stop its phase 3 kidney outcomes trial evaluating semaglutide in adults with type 2 diabetes and chronic kidney disease (CKD) based on interim data demonstrating efficacy. The randomized, double-blind, parallel-group, placebo-controlled …
Thomas W. Gardner, MD, MS
https://reachmd.com/profiles/thomas-w-gardner-md-ms/7vk4Ko/
Thomas W. Gardner, MD, MS, is Professor of Ophthalmology and Visual Sciences and Molecular and Integrative Physiology at the University of Michigan. He practiced comprehensive ophthalmology in Franklin, Pennsylvania, and was the Jack and Nancy Turner Professor of Ophthalmology and Cellular and Mole…
Lee Merrill Jampol, MD
https://reachmd.com/profiles/lee-merrill-jampol-md/L0AP88/
I am a full-time faculty member at Northwestern University. My career has focused on clinical trials, inflammatory diseases of the retina, cystoid macular edema, pharmacology of the retina and central serous chorioretinopathy. I have also been extensively involved in clinical and research work on d…
Paul Jellinger
https://reachmd.com/profiles/paul-jellinger/jGaBad/
Paul S. Jellinger, MD, MACE, is Professor of Medicine on the voluntary faculty at the University of Miami, Florida. After receiving his medical degree from Wayne State University School of Medicine, he completed a first-year medical residency at Beth Israel Hospital and a second-year residency at …
Timothy Bailey, MD
https://reachmd.com/profiles/timothy-bailey-md/LyPyzO/
Timothy Bailey, MD, FACE, FACP, CPI was born in New York City. Having lost an uncle from the ravages of type 1 diabetes while a teen, he became interested in medicine. At Mount Sinai he was mentored by Elliot Rayfield, MD, FACE and chose to train in endocrinology & metabolism with Harold Lebovitz, …
Louis Philipson, MD, PhD
https://reachmd.com/profiles/louis-philipson-md-phd/OeDRpj/
Dr. Louis H. Philipson is a Professor of Endocrinology in the Department of Medicine of the University of Chicago Medical Center. He also serves on the Committee on Cell Physiology. Dr. Philipson's research focuses on how pancreatic Beta-cells "know" when to secrete insulin and define defects in th…